Actively Recruiting
MRgLITT for mTLE: A PROBE Trial
Led by Beijing Tiantan Hospital · Updated on 2026-01-21
120
Participants Needed
1
Research Sites
127 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
How does magnetic resonance-guided laser interstitial thermal therapy (MRgLITT) impact clinical prognosis in mesial temporal lobe epilepsy (mTLE)?
CONDITIONS
Official Title
MRgLITT for mTLE: A PROBE Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 65 years
- Diagnosed with drug-resistant mesial temporal lobe epilepsy
- Experience seizures at least once per month
- Approved to participate in the study
You will not qualify if you...
- History of brain surgery
- Presence of intracranial space occupying lesions
- Significant medical conditions posing high surgery risk, such as severe cardiovascular disease, respiratory disorders, or uncontrolled systemic infections
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Beijing Tiantan Hospital
Beijing, Beijing Municipality, China, 100070
Actively Recruiting
Research Team
K
Kai Zhang, Dr.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here